Literature DB >> 32392513

Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events.

Theodore Wein1, M Patrice Lindsay2, David J Gladstone1, Alexandre Poppe1, Alan Bell1, Leanne K Casaubon1, Norine Foley1, Shelagh B Coutts1, Jafna Cox1, James Douketis1, Thalia Field1, Laura Gioia1, Jeffrey Habert1, Eddy Lang1, Shamir R Mehta1, Christine Papoushek1, William Semchuk1, Mikul Sharma1, Jacob A Udell1, Stephanie Lawrence1, Anita Mountain1, Gord Gubitz1, Dar Dowlatshahi1, Anne Simard1, Andrea de Jong1, Eric E Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32392513      PMCID: PMC7101172          DOI: 10.1503/cmaj.191599

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  38 in total

1.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.

Authors:  Martin J O'Donnell; Siu Lim Chin; Sumathy Rangarajan; Denis Xavier; Lisheng Liu; Hongye Zhang; Purnima Rao-Melacini; Xiaohe Zhang; Prem Pais; Steven Agapay; Patricio Lopez-Jaramillo; Albertino Damasceno; Peter Langhorne; Matthew J McQueen; Annika Rosengren; Mahshid Dehghan; Graeme J Hankey; Antonio L Dans; Ahmed Elsayed; Alvaro Avezum; Charles Mondo; Hans-Christoph Diener; Danuta Ryglewicz; Anna Czlonkowska; Nana Pogosova; Christian Weimar; Romaina Iqbal; Rafael Diaz; Khalid Yusoff; Afzalhussein Yusufali; Aytekin Oguz; Xingyu Wang; Ernesto Penaherrera; Fernando Lanas; Okechukwu S Ogah; Adesola Ogunniyi; Helle K Iversen; German Malaga; Zvonko Rumboldt; Shahram Oveisgharan; Fawaz Al Hussain; Daliwonga Magazi; Yongchai Nilanont; John Ferguson; Guillaume Pare; Salim Yusuf
Journal:  Lancet       Date:  2016-07-16       Impact factor: 79.321

2.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1997-03       Impact factor: 4.634

3.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

4.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

5.  Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2016-04-12       Impact factor: 25.391

6.  Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group.

Authors:  R Côté; R N Battista; M Abrahamowicz; Y Langlois; F Bourque; A Mackey
Journal:  Ann Intern Med       Date:  1995-11-01       Impact factor: 25.391

7.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

8.  Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

Authors:  John J McNeil; Mark R Nelson; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Christopher M Reid; Brenda Kirpach; Raj C Shah; Diane G Ives; Elsdon Storey; Joanne Ryan; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

9.  Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; Nancy R Cook; J Michael Gaziano; Jacqueline F Price; Jill F F Belch; Maria Carla Roncaglioni; Takeshi Morimoto; Ziyah Mehta
Journal:  Lancet       Date:  2018-07-17       Impact factor: 79.321

10.  Interventions to support shared decision making for hypertension: A systematic review of controlled studies.

Authors:  Rachel A Johnson; Alyson Huntley; Rachael A Hughes; Helen Cramer; Katrina M Turner; Ben Perkins; Gene Feder
Journal:  Health Expect       Date:  2018-09-17       Impact factor: 3.377

View more
  4 in total

1.  New Canadian guideline is wrong to say acetylsalicylic acid is only for patients with symptomatic vascular disease.

Authors:  J David Spence
Journal:  CMAJ       Date:  2020-06-15       Impact factor: 8.262

2.  Rapid recommendations: Updates from 2020 guidelines: part 1.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

3. 

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

4.  Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment.

Authors:  Eric E Smith; Philip Barber; Thalia S Field; Aravind Ganesh; Vladimir Hachinski; David B Hogan; Krista L Lanctôt; M Patrice Lindsay; Mukul Sharma; Richard H Swartz; Zahinoor Ismail; Serge Gauthier; Sandra E Black
Journal:  Alzheimers Dement (N Y)       Date:  2020-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.